Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5387 ARTÍCULOS , VIENDO DEL 4621 AL 4635

Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis

Wade DT, Collin C, Stott C, Duncombe P.

Mult Scler. 2010 Jun;16(6):707-14. doi: 10.1177/1352458510367462.

Oral dantrolene and severe respiratory failure in a patient with chronic spinal cord injury

Javed M, Bogdanov A.

Anaesthesia. 2010 Aug;65(8):855-6. doi: 10.1111/j.1365-2044.2010.06409.x. Epub 2010 Jun 17.

Pharmacological management of pain in patients with multiple sclerosis

Solaro C, Messmer Uccelli M.

Drugs. 2010 Jul 9;70(10):1245-54. doi: 10.2165/11537930-000000000-00000.

Effect of botulinum toxin type A, motor imagery and motor observation on motor function of hemiparetic upper limb after stroke

Santamato A, Panza F, Filoni S, Ranieri M, Solfrizzi V, Frisardi V, Dellomonaco A, Amoruso MT, Amoruso L, Kehoe PG, Megna M, Fiore P.

Brain Inj. 2010;24(9):1108-12. doi: 10.3109/02699052.2010.494591.

Botulinum toxin type A in post-stroke upper limb spasticity

Kaji R, Osako Y, Suyama K, Maeda T, Uechi Y, Iwasaki M; GSK1358820 Spasticity Study Group.

Curr Med Res Opin. 2010 Aug;26(8):1983-92. doi: 10.1185/03007995.2010.497103.

Effect of acute unloaded arm versus leg cycling exercise on the soleus H-reflex in adults with multiple sclerosis

Sosnoff JJ, Motl RW.

Neurosci Lett. 2010 Aug 2;479(3):307-11. doi: 10.1016/j.neulet.2010.05.086. Epub 2010 Jun 4.

[Clinical research of electroacupuncture combined with acupoint-injection of botulinum toxin A in treating the muscle spasticity by spinal cord injury]

Xing ST, Wang D, Wen XH, Wu ZQ, Sun Q, Zhang DW, Cheng Y, Yan D, Yu F.

Zhongguo Gu Shang. 2010 May;23(5):350-3.

Clinical assessment and management of spasticity: a review

Rekand T.

Acta Neurol Scand Suppl. 2010;(190):62-6. doi: 10.1111/j.1600-0404.2010.01378.x.

Cannabinoid CB1 receptor-interacting proteins: novel targets for central nervous system drug discovery?

Smith TH, Sim-Selley LJ, Selley DE.

Br J Pharmacol. 2010 Jun;160(3):454-66. doi: 10.1111/j.1476-5381.2010.00777.x.

Discordance in informed consent response on the basis of demographic factors: brief report

Nunez-Wallace KR, Gill CE, Harrison CH, Taylor HM, Charles PD.

Intellect Dev Disabil. 2010 Jun;48(3):175-9. doi: 10.1352/1944-7558-48.3.175.

Selective tibial neurotomy in the treatment of spastic equinovarus foot in hemiplegic patients: a 2-year longitudinal follow-up of 30 cases

Deltombe T, Gustin T.

Arch Phys Med Rehabil. 2010 Jul;91(7):1025-30. doi: 10.1016/j.apmr.2010.04.010.

Neural mechanism and clinical significance of the plantar grasp reflex in infants

Futagi Y, Suzuki Y.

Pediatr Neurol. 2010 Aug;43(2):81-6. doi: 10.1016/j.pediatrneurol.2010.04.002.

The place of the botulinum toxin in the management of multiple sclerosis

Habek M, Karni A, Balash Y, Gurevich T.

Clin Neurol Neurosurg. 2010 Sep;112(7):592-6. doi: 10.1016/j.clineuro.2010.04.010. Epub 2010 Jul 8.

Botulinum toxin assessment, intervention and after-care for lower limb spasticity in children with cerebral palsy: international consensus statement

Love SC, Novak I, Kentish M, Desloovere K, Heinen F, Molenaers G, O'Flaherty S, Graham HK; Cerebral Palsy Institute.

Eur J Neurol. 2010 Aug;17 Suppl 2:9-37. doi: 10.1111/j.1468-1331.2010.03126.x.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias